Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Pancreatic Cancer
71%
Gemcitabine
36%
Tumorigenesis
30%
Tumor
29%
Chemotherapy
28%
Metastatic Pancreatic Ductal Adenocarcinoma
22%
Pancreatic Duct Cells
20%
Nab-paclitaxel
20%
Oncogenic Ras
19%
Patient-derived Xenograft
19%
RalA
16%
CCR2
16%
Overall Survival
15%
Tumor Microenvironment
15%
Mitogen-activated Protein Kinase
15%
KRAS-mutant Cancer
15%
Tumor Growth
14%
Transcriptome
14%
Extracellular Signal-regulated Kinase
14%
Chemoresistance
14%
Neoadjuvant
14%
In Cancer
13%
Colorectal Cancer
13%
K-ras
13%
NF-B
13%
Poor Prognosis
12%
Tumor Maintenance
12%
Cancer-associated Fibroblasts
11%
Resectable Pancreatic Cancer
11%
Gallbladder Cancer
11%
Toll-like
11%
Tumor-associated Macrophages
11%
Oncogene
10%
Gastrointestinal Cancer
10%
RalB
10%
Targeted Treatment
10%
Inflammatory Pathways
10%
FOLFIRINOX
10%
Human Cancer
10%
Borderline Resectable
9%
Tumor Cells
9%
Pembrolizumab
9%
Phase Ib Study
9%
Comprehensive Characterization
9%
Metastatic Colorectal Cancer (mCRC)
9%
Liposomal Irinotecan
9%
Ulixertinib
9%
Diffuse Large B-cell Lymphoma (DLBCL)
9%
IRAK4
9%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
85%
Pancreas Cancer
71%
Carcinogenesis
37%
Gemcitabine
35%
Malignant Neoplasm
34%
Neoplasm
33%
Chemotherapy
32%
Diseases
31%
Clinical Trial
20%
Paclitaxel
20%
Fluorouracil
17%
Progression Free Survival
17%
Overall Survival
17%
Folinic Acid
16%
Drug Resistance
16%
Tumor Growth
15%
Protein Kinase B
13%
Immunotherapy
12%
Oxaliplatin
12%
Bile Duct Carcinoma
12%
Digestive System Cancer
11%
Tumor Microenvironment
10%
Adenocarcinoma
10%
Adverse Event
10%
Mitogen Activated Protein Kinase
10%
Diarrhea
9%
Irinotecan Sucrosofate
9%
Ulixertinib
9%
Colorectal Carcinoma
8%
Irinotecan
8%
Gallbladder Cancer
8%
Focal Adhesion Kinase
8%
Janus Kinase 1
8%
Neutropenia
7%
Pancreas Carcinoma
7%
Tolerability
6%
Mouse Model
6%
Phosphotransferase
6%
Receptor
6%
Biliary Tract Cancer
6%
Liver Cell Carcinoma
5%
Focal Adhesion Kinase Inhibitor
5%
Solid Malignant Neoplasm
5%
Toll Like Receptor 9
5%
Chemokine Receptor
5%
Beta Chemokine
5%
Defactinib
5%
Febrile Neutropenia
5%
Fibrosis
5%
Medicine and Dentistry
Pancreas Adenocarcinoma
83%
Pancreas Cancer
65%
Neoplasm
31%
Gemcitabine
25%
Diseases
22%
Malignant Neoplasm
19%
Immunotherapy
17%
Cancer
16%
Overall Survival
15%
Tumor
15%
Drive
15%
Clinical Trial
14%
Carcinogenesis
14%
Stroma
12%
Metastatic Carcinoma
12%
Cholangiocarcinoma
12%
Progression Free Survival
11%
Hepatocellular Carcinoma
11%
Paclitaxel
10%
Ras Signaling
10%
Radiation Therapy
10%
Mitogen-Activated Protein Kinase
10%
Chemokine Receptor
10%
Gastrointestinal Cancer
10%
Diffuse Large B-Cell Lymphoma
9%
Intraarterial Drug Administration
9%
Common Hepatic Artery
9%
Interleukin 1 Receptor Associated Kinase 4
9%
Nivolumab
9%
Cancer Associated Fibroblast
8%
Gallbladder Cancer
8%
Adenocarcinoma
7%
Tumor Microenvironment
7%
Tumor Cell
7%
Positron Emission Tomography
7%
Janus Kinase 1
7%
Focal Adhesion Kinase
7%
Nuclear Factor
7%
Alternative Complement Pathway C3 C5 Convertase
7%
Colorectal Carcinoma
6%
B Cell
6%
Systemic Therapy
6%
Phosphotransferase
6%
Proteomics
6%
Drug Resistance
6%
Cancer Types
6%
Biliary Duct Cancer
6%
Polyethylene Terephthalate
6%
Small GTPase
6%
Colorectal Liver Metastasis
6%